MedLife S.A. — AGM Information 2020

Apr 14, 2020

MED LIFE S.A. Sediul social: București, Calea Griviței, nr. 365, sector 1, România Codul de înregistrare fiscală: 8422035 Număr de ordine în Registrul Comerţului: J40/3709/1996 Capital social subscris şi vărsat: 5.536.270,5 RON

No 81/14.04.2020

CURRENT REPORT

according to FSA Regulation no. 5/2020 for the adoption of measures regarding the conduct of the general meetings of shareholders of the issuers during the state of emergency generated by

COVID-19

Report Date: 14 April 2020

Name of the issuing company: MED LIFE S.A. ("MedLife" or "The Company")

Registered Office: Bucharest, Calea Grivitei, no. 365, district 1, Romania

Fax number: 0374 180 470

Unique Registration Code at the National Office of Trade Registry: 8422035

Order number on the Trade Registry: J40/3709/1996

Subscribed and paid-in share capital: 5,536,270.5 RON

Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category

Significant events to report:

Information and recommendations during COVID-19 pandemic regarding the holding, participation and voting in the ordinary and extraordinary general meetings of shareholders of MED LIFE S.A. scheduled for 23 / 24.04.2020 ("OGMS / EGMS")

In view of (i) the current exceptional situation caused globally by COVID-19 virus and (ii) the establishment of a state of emergency, as well as the preventive measures taken by the Romanian authorities, such as the limitations on the assemblies of persons and the traffic restrictions, we emphasize the fact that MED LIFE SA (The "Company") complies with such measures in relation to the OGMS / EGMS, in accordance with those imposed by the authorities and with the recommendations issued by the Financial Supervisory Authority through the FSA Regulation no. 5/2020. In this regard, the Company recommends to the shareholders to use electronic means / remote interaction regarding the OGMS / EGMS, within the terms and conditions provided by the OGMS / EGMS convening notice published on 23.03.2020 https://www.medlifeinternational.com/public\files/documente\_bursa/raport\_curent\_convocator\ en.pdf , such as:

I. accessing the materials related to the OGMS / EGMS on electronic format, avoiding, as much as possible, sending / obtaining them in physical copy, by mail, courier services or personally picking up, from the Company's headquarters. The materials related to the items on the agenda of the OGMS / EGMS are available on the Company's website https://www.medlifeinternational.com/investor-relations/gmsdocuments

II. the transmission by the shareholders (i) of the questions regarding the OGMS / EGMS, (ii) of the general power of attorney or, as the case may be, of the special power of attorney and (iii) of the votes by correspondence, by e-mail to investors@medlife.ro, using the electronic signature according to those described in the notice, avoiding, as much as possible, their transmission in physical copy by mail, courier services or personally delivering at the Company's Register.

The Company also informs investors about the following aspects:

• The company will be able to apply the restrictions in force at the date of the OGMS / EGMS, regarding the limitation of the number of participants to events held in closed spaces, only according to the express decisions taken by the authorities;

• WARNING - participation at public events / meetings held in closed spaces, such as OGMS / EGMS, under the conditions imposed by the authorities at that particular time, exposes the participants to a possible contamination with the SAR-CoV-2 coronavirus, and the Company or its management cannot be held liable for such risk.

We consider that, under these extreme conditions produced by COVID-19, it would be optimal for the OGMS and OGMS to be kept as much as possible without the physical participation of the shareholders (except for the meeting secretary). We also recommend that any shareholder / his representative who will physically participate in the OGMS / OGMS comply with the authorities' recommendations regarding the state of health and ensure that they do not present the specific COVID-19 symptoms.

Depending on the future developments of the situation created by COVID-19 between the time of publication of this report and the date of holding the OGMS / OGMS, we will take the appropriate measures, required or imposed by the authorities and we undertake to keep the shareholders of the Company informed as soon as possible regarding the OGMS / EGMS. In case the OGMS / EGMS cannot be held with the physical presence of the shareholders as a result of the express decisions taken by the authorities, the Company will ensure the OGMS / EGMS using the correspondence vote, according to the legal provisions.

Further information can also be obtained from Investor Relations Department, on the phone number +40 730 593 022 and on the Company's website www.medlifeinternational.com.

__________________ Mihail Marcu Chairman of the Board of Directors